Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

EARNINGS AND TRADING: Optima says full-year revenue up as expected

16th Jun 2026 13:21

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

----------

Optima Health PLC - occupational health services provider - Issues a trading update for the financial year ended March 31, reporting revenue of approximately GBP121 million. This would be up 15% from GBP105 million the year before, which Optima says is in line with market expectations. Notes that other income of GBP4.7 million was recognised relating to a previously disclosed procurement matter. Reiterates that it expects adjusted earnings before interest, tax, depreciation and amortisation to be about 10% higher than previous market guidance. Reports a net debt position of GBP94.4 million as of March 31, with a GBP21.6 million cash balance and GBP116 million of debt, but says net debt has reduced as of the end of May following repayment of a GBP30 million shareholder bridging loan for its March acquisition of PAM, which as of June 1 has delivered GBP1.3 million of annualised cost synergies. Says it continues to make strong progress against its strategic objectives and medium‑term targets of GBP200 million in annual revenue and GBP40 million of adjusted Ebitda. Expects to report full-year results in August.

----------

Accsys Technologies PLC - London-based wood building products manufacturer - Reports group revenue of EUR153 million for the year ended March 31, up 12% or 20% like-for-like, from EUR137 million the year before. Underlying Ebitda rises 26% to EUR21.1 million from EUR16.8 million, while adjusted Ebitda rises 96% to EUR21.2 million from EUR10.8 million. Pretax loss narrows to EUR570,000 from EUR20.8 million. Says its LFL revenue growth was driven by a solid trading performance across all regions, continued pricing discipline, and a favourable sales mix with a higher year-on-year proportion of Accoya Color sales. Accoya sales volumes increases 21%, while revenue from its Accoya USA joint venture more than doubles to EUR30.3 million from EUR10.9 million. The JV also swings to Ebitda profitability of EUR90,000 from an EUR6.0 million loss, partially driving the group adjusted Ebitda surge. Accsys says trading is in line with expectations for financial 2027, and that it is on track to achieve the phase 1 targets of its 'FOCUS' strategy. "While macroeconomic conditions remain uncertain with some inflationary pressures arising from the conflict in the Middle East, we are well positioned to manage the potential impact through product differentiation, geographical diversification, and pricing discipline," Accsys says.

----------

US Solar Fund PLC - investor in utility-scale solar power plants across North America - Says net asset value for its first quarter ended March 31 "remained stable" at 62 US cents per share, up by around 2.0% quarter-on-quarter. Says portfolio generation for the period was 8.8% below its forecast, compared with previous long-term forecasts, and underperforms by 0.9% against its revised forecasts for 2026. Attributes the underperformance against long-term forecasts to "technical (non-weather) factors", partially offset by favourable weather conditions. Expects a lower first-half performance to be offset by higher performance in the second, once work on its Chiloquin asset is completed. "As such performance when compared to the revised forecasts for 2026 has largely been in line with expectations," the company says. Also notes an "improved performance" from its two Californian assets, and says overall performance continued to be impacted by lead times and utility grid outages, "although to a lesser extent than the prior 12-month period". USF says the potential sale announced on May 18 of its solar generation assets, having granted the prospective buyer a 90-day exclusivity period, remains subject to due diligence and legal documentation discussions.

----------

By Emma Curzon, Alliance News reporter

Comments and questions to [email protected]

Copyright 2026 Alliance News Ltd. All Rights Reserved.


Related Shares:

Optima HealthAccsys TechUs Solar Fund
FTSE 100 Latest
Value10,399.70
Change-108.91